Additional information
White powder
1443118-73-7
ACI-018216
179.7-181.9°C
C22H20N4OS
388.49
Ambient
2-8°C
Antineoplastic
Pharmaceutical Impurity Standards
N-methyl-2-((3-(2-(pyridin-2-yl)ethyl)-1H-indazol-6-yl)thio)benzamide (Dihydro-Axitinib)
N-methyl-2-((3-(2-(pyridin-2-yl)ethyl)-1H-indazol-6-yl)thio)benzamide
Benzamide, N-methyl-2-[[3-[2-(2-pyridinyl)ethyl]-1H-indazol-6-yl]thio]





![N-BOC-N-DESHYDROXYETHYL DASATINIB (25 mg) (2-Methyl-2-propanyl 4-[6-({5-[(2-chloro-6-methylphenyl)carbamoyl]-1,3-thiazol-2-yl}amino)-2-methyl-4-pyrimidinyl]-1-piperazinecarboxylate )](https://analyticachemie.in/wp-content/uploads/uspimage-1.jpg)